India consults on marketing approval guidance for fixed dose combinations
This article was originally published in Scrip
Executive Summary
India's drug regulatory agency, the Central Drugs Standard Control Organization (CDSCO), has issued for consultation draft guidance on requirements for gaining marketing approval of fixed dose combinations or FDCs, ie a formulation of two or more active ingredients combined in a single dosage form.